Showing 1 - 10 of 1,896
most attractive destinations to technology intensive FDI, for instance, pharmaceutical FDI. To explore whether patent … measuring the pharmaceutical patent protection in China (PPP index) to analyze its correlation with inward pharmaceutical FDI … literature - the most sensitive to patent protection, i.e., drugs producing and/or research and development (R&D) FDI. Our …
Persistent link: https://www.econbiz.de/10012794273
Persistent link: https://www.econbiz.de/10012815671
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP....
Persistent link: https://www.econbiz.de/10012247334
Persistent link: https://www.econbiz.de/10012609439
Persistent link: https://www.econbiz.de/10003965689
Persistent link: https://www.econbiz.de/10003756813
rights (IPR) regimes. Weak IPR regimes usually feature weak patent enforcement, such as relatively low level of compensation … among utility models- the type of patents inferior to invention patents. I also document that China’s patent infringement …. These empirical patterns suggest that weak IPR regimes might create a “lemon market” for patent protection in which truly …
Persistent link: https://www.econbiz.de/10014078171
Though it lacked a patent system until 1985, China is now the world leader in patent filings and litigation. Despite … the meteoric rise of the Chinese patent system, many in the West believe that it acts primarily to facilitate local … protectionism rather than innovation. Recent high-profile patent suits filed by relatively unknown Chinese firms against high …
Persistent link: https://www.econbiz.de/10014129228
Persistent link: https://www.econbiz.de/10013282621
Persistent link: https://www.econbiz.de/10013484806